本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AIM ImmunoTech Inc.

0.2540
0.0000
盤後0.25800.0040+1.57%19:52 EDT
成交量:65.96萬
成交額:16.78萬
市值:773.23萬
市盈率:-0.06
高:0.2620
開:0.2540
低:0.2497
收:0.2540
52周最高:2.98
52周最低:0.1901
股本:3,044.21萬
流通股本:2,850.63萬
量比:0.94
換手率:2.31%
股息:- -
股息率:- -
每股收益(TTM):-3.9303
每股收益(LYR):-30.8884
淨資產收益率:-2382.30%
總資產收益率:-82.58%
市淨率:1.00
市盈率(LYR):-0.01

資料載入中...

2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/31

SEC問詢函

Form CORRESP - Correspondence
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/11

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/30

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/20

SEC問詢函

Form CORRESP - Correspondence
2024/07/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/12

SEC問詢函

Form CORRESP - Correspondence
2024/07/11

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/26

SEC問詢函

Form CORRESP - Correspondence